Aromatase Inhibitors (14 Offers)
Manufacturer: Kalpa Pharmaceuticals
Substance: Exemestane
Pack: 30 tabs (25 mg/tab)
Manufacturer: Kalpa Pharmaceuticals
Substance: Letrozole
Pack: 30 tabs (2.5 mg/tab)
Manufacturer: Kalpa Pharmaceuticals LTD, India
Substance: Anastrozole
Pack: 1 mg/tab, 100 tabs
Manufacturer: Dragon Pharma, Europe
Substance: Anastrozole
Pack: 1 mg/tab, 100 tabs
Manufacturer: Dragon Pharma, Europe
Substance: Exemestane
Pack: 25 mg, 100 tabs
Manufacturer: British Dragon Pharmaceuticals
Pharmaceutical name: Anastrozole
Pack: 50 tabs (1 mg/tab)
Manufacturer: Gen-Shi Laboratories
Substance: Anastrozole
Pack: 2 mg/tab, 100 tabs
Manufacturer: Stealth Labs
Substance: Anastrozole
Pack: 2 mg/tabs, 100 tabs
Manufacturer: Dragon Pharma, Europe
Substance: Letrozole
Pack: 2.5 mg/tab, 100 tabs
Manufacturer: British Dragon Pharmaceuticals
Substance: Exemestane
Pack: 25 mg/tab, 100 tabs
Manufacturer: British Dragon Pharmaceuticals
Substance: Letrozole
Pack: 2.5 mg/tab, 100 tabs
Manufacturer: British Dragon Pharmaceuticals
Substance: Anastrozole
Pack: 1 mg/tab, 100 tabs
Beyond oncology, aromatase inhibitors are also studied for their potential applications in other medical conditions influenced by estrogen levels. However, their primary and most well-established use remains in the treatment of hormone receptor-positive breast cancer.
While effective, aromatase inhibitors can have side effects, including joint pain, osteoporosis, and hot flashes, due to the lowered estrogen levels. Therefore, their use requires careful medical supervision to balance benefits and potential risks. Overall, aromatase inhibitors represent a significant advancement in targeted cancer therapy, offering hope for improved outcomes in hormone-dependent cancers.
